Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Targeted Mass Drug Administration and Reactive Case Detection on Malaria Transmission and Elimination in East Hararghe Zone, Oromia, Ethiopia

NCT04241705 is registered in ClinicalTrials.gov with Armauer Hansen Research Institute, Ethiopia as lead sponsor.

NCT NCT04241705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04241705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Targeted Mass Drug Administration and Reactive Case Detection on Malaria Transmission and Elimination in East Hararghe Zone, Oromia, Ethiopia
Lead sponsor
Armauer Hansen Research Institute, Ethiopia
Phase
Not applicable
Overall status
Unknown status
Start date
January 20, 2020
Completion date
January 20, 2022
Enrollment
48,960 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

malaria